For the Inventor, By the Inventor

Enter assignee name

High Point, NC, United States of America

Vtv Therapeutics LLC

Calculating rank

USPTO Granted Patents = 54

% Expired Patents = 1.9

CIPO Patents = 3

EPO Patents = 13

Trademarks = 3

Forward Citations = 189

Loading Chart...

Loading Chart...

53 inventors (with patents filed for the assignee):

Dharma Rao Polisetti (22 out of 53 patents)

Adnan M M Mjalli (20 out of 74 patents)

Matthew J Kostura (17 out of 23 patents)

4. Mustafa Guzel (16 out of 34 patents)

5. Maria Carmen Valcarce Lopez (15 out of 16 patents)

6. Otis Clinton Attucks (12 out of 13 patents)

7. Robert Carl Andrews (12 out of 53 patents)

8. Bapu Reddy Gaddam (12 out of 21 patents)

9. Jareer Nabeel Kassis (9 out of 10 patents)

10. Suparna Gupta (8 out of 18 patents)

11. Samuel F Victory (7 out of 14 patents)

12. Per Sauerberg (5 out of 99 patents)

13. Pavel Pihera (5 out of 11 patents)

14. Zdenek Polivka (5 out of 31 patents)

15. Miroslav Havranek (5 out of 14 patents)

Core Competencies:

Glucokinase Activators

PPAR Delta Agonists

Imidazole Derivatives

Tricyclic Compounds

Oxidative Stress Modulators

Diabetes Treatment

Alzheimer's Disease

Pharmaceutical Compositions

54 patents: Sort by Forward Citations

1. 12698283 - Quinoline derivatives, pharmaceutically acceptable salts, and methods of use thereof (2026-08-04),

2. 12545676 - Crystalline form of hydrochloride salt of quinoline derivative (2026-02-10),

3. 12479808 - Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof (2025-11-25),

4. 12391658 - Sulfoxide and sulfone glucokinase activators and methods of use thereof (2025-08-19),

5. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2024-09-17),

6. 11974989 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2024-05-07),

7. 11970457 - Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine (2024-04-30),

8. 11883383 - Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine (2024-01-30),

9. 11833136 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2023-12-05),

10. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2023-05-16),

11. 11524942 - Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine (2022-12-13),

12. 11420942 - Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine (2022-08-23),

13. 11420929 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2022-08-23),

14. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-09-28),

15. 11096946 - Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb (2021-08-24),

Company Overview

Vtv Therapeutics LLC, based in High Point, NC, specializes in the development of innovative pharmaceutical compositions aimed at addressing significant health challenges. The company focuses on core technology areas such as glucokinase activators and PPAR delta agonists, which are pivotal in the treatment of diabetes and related metabolic disorders. Additionally, Vtv is engaged in research on imidazole derivatives and tricyclic compounds, exploring their potential in managing oxidative stress and neurodegenerative diseases like Alzheimer's. Their commitment to advancing therapeutic solutions reflects a dedication to improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

54 Patents

#2 in High Point, NC

#158 in North Carolina

#6,573 in US

#13,146 in the World

High Point, NC, United States of America

Vtv Therapeutics LLC

Forward Citations = 189

53 inventors:

Dharma Rao Polisetti (22 out of 53 patents)

Adnan M M Mjalli (20 out of 74 patents)

Matthew J Kostura (17 out of 23 patents)

4. Mustafa Guzel (16 out of 34 patents)

5. Maria Carmen Valcarce Lopez (15 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vtv Therapeutics LLC. Retrieved from https://idiyas.com/company/vtv-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…